A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis - Concepedia

Concepedia

Publication | Closed Access

A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis

26

Citations

40

References

2014

Year

Jad El‐Hoss, Tegan L. Cheng, Eleanor C Carpenter, Kathleen E. Sullivan, Nikita Deo, Kathy Mikulec, David G. Little, Aaron Schindeler

Journal of Bone and Joint Surgery

Abstract

This study examines a signaling pathway-based approach to treating poor bone healing in a model of NF1 pseudarthrosis.

References

	Year	Citations

Page 1